Skip to content
中文产业新闻精选评分75Chinese source

Moderna 流感 mRNA 疫苗 mFLUSIVA 获 FDA 批准，适用于 50 岁及以上人群

又一款mRNA疫苗获批！Moderna的mFLUSIVA为全球首款流感mRNA疫苗

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.